Comparison among conventional and advanced MRI,  18 F-FDG PET/CT, phenotype and genotype in glioblastoma

Maria Consuelo Valentini; Marta Mellai; Laura Annovazzi; Antonio Melcarne; Tetyana Denysenko; Paola Cassoni; Cristina Casalone; Cristiana Maurella; Silvia Grifoni; Piercarlo Fania; Angelina Cistaro; Davide Schiffer

doi:10.18632/oncotarget.21482

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Comparison among conventional and advanced MRI, ¹⁸F-FDG PET/CT, phenotype and genotype in glioblastoma

Maria Consuelo Valentini, Marta Mellai, Laura Annovazzi, Antonio Melcarne, Tetyana Denysenko, Paola Cassoni, Cristina Casalone, Cristiana Maurella, Silvia Grifoni, Piercarlo Fania, Angelina Cistaro and Davide Schiffer _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:91636-91653. https://doi.org/10.18632/oncotarget.21482

Metrics: PDF 1325 views | HTML 2432 views | ?

Abstract

Maria Consuelo Valentini1, Marta Mellai2, Laura Annovazzi2, Antonio Melcarne3, Tetyana Denysenko2, Paola Cassoni4, Cristina Casalone5, Cristiana Maurella5, Silvia Grifoni5, Piercarlo Fania6, Angelina Cistaro6,7 and Davide Schiffer2

1Department of Neuroradiology, A.O.U. Città della Salute e della Scienza, 10126 Turin, Italy

2Research Center/Policlinico di Monza Foundation, 13100 Vercelli, Italy

3Department of Neurosurgery, A.O.U. Città della Salute e della Scienza, 10126 Turin, Italy

4Department of Medical Sciences, University of Turin, 10126 Turin, Italy

5Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, 10154 Turin, Italy

6Positron Emission Tomography Center IRMET S.p.A, Euromedic Inc., 10136 Turin, Italy

7Institute of Cognitive Sciences and Technologies, National Research Council, 00185 Rome, Italy

Correspondence to:

Davide Schiffer, email: [email protected]

Keywords: glioblastoma, MRI, ¹⁸F-FDG PET/CT, phenotype, genotype

Received: November 15, 2016 Accepted: July 30, 2017 Published: October 04, 2017

ABSTRACT

Glioblastoma (GB) is a highly heterogeneous tumor. In order to identify in vivo the most malignant tumor areas, the extent of tumor infiltration and the sites giving origin to GB stem cells (GSCs), we combined positron emission tomography/computed tomography (PET/CT) and conventional and advanced magnetic resonance imaging (MRI) with histology, immunohistochemistry and molecular genetics. Prior to dura opening and tumor resection, forty-eight biopsy specimens [23 of contrast-enhancing (CE) and 25 of non-contrast enhancing (NE) regions] from 12 GB patients were obtained by a frameless image-guided stereotactic biopsy technique.

The highest values of 2-[18F]-fluoro-2-deoxy-D-glucose maximum standardized uptake value (¹⁸F-FDG SUV_max), relative cerebral blood volume (rCBV), Choline/Creatine (Cho/Cr), Choline/N-acetylaspartate (Cho/NAA) and Lipids/Lactate (LL) ratio have been observed in the CE region. They corresponded to the most malignant tumor phenotype, to the greatest molecular spectrum and stem cell potential. On the contrary, apparent diffusion coefficient (ADC) and fractional anisotropy (FA) in the CE region were very variable.

¹⁸F-FDG SUV_max, Cho/Cr and Cho/NAA ratio resulted the most suitable parameters to detect tumor infiltration. In edematous areas, reactive astrocytes and microglia/macrophages were influencing variables.

Combined MRI and ¹⁸F-FDG PET/CT allowed to recognize the specific biological significance of the different identified areas of GB.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21482

Publication Alerts

Research Papers:

Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma

Abstract

Comparison among conventional and advanced MRI, ¹⁸F-FDG PET/CT, phenotype and genotype in glioblastoma